Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
The completion of a Phase I trial is a significant milestone, as its primary objective is to assess safety and tolerability in human subjects
Published scientific literature has discussed these peptides in laboratory studies involving peptide biology, molecular signaling, receptor biology, protein interactions, extracellular matrix research, analytical chemistry, and experimental peptide models
Only around three small pilot studies exist
Retatrutide at the 12 mg dose produced nausea in 38-43% of Phase 3 trial participants
US$ 21.16
US$ 20.96
US$ 23.18
